![IDOVEN](https://cdn.prod.website-files.com/64897d6862a1de6911aaa119/6602cd9e95d800950cdd53c9_idoven-logo-rectangle.webp)
IDOVEN
![IDOVEN team, part of the Private Equity manager's portfolio Insight Partners](https://cdn.prod.website-files.com/64897d6862a1de6911aaa119/6602cda5268c8eca0c5dc0ea_idoven-equipe.webp)
![](https://cdn.prod.website-files.com/64897d6862a1de6911aaa119/6602cddbcef5317d0fd2a2aa_idoven-collaboratrice.webp)
Spanish company Idoven is establishing itself as a key player in the early detection and precision medicine of cardiovascular diseases. These diseases, which are notoriously difficult to identify and diagnose due to the absence of specific symptoms in their early stages, are at the heart of medical concerns.
After suffering a heart attack in 2019 at the age of 38, Real Madrid star Iker Casillas, who played for the team from 1999 to 2015, was forced to call time on his career. A few weeks after his release from hospital, he decided to invest in Idoven and become its international ambassador. Manuel Marina-Breysse, Idoven's founder, explained to AFP: "He was aware that technology had to help fight this disease, when one person dies every two seconds worldwide from cardiac arrest."
Idoven was the first company in the world to develop artificial intelligence software to help cardiologists with their diagnosis. Thanks to its cloud-based platform, this AI enables doctors to analyze electrocardiogram data and predict potential risks of cardiac arrhythmia. Idoven's software identifies 86 cardiac rhythm disorders, representing 90% of the most common heart problems.
In addition, the company continues to develop its platform, benefiting from collaborations with 17 renowned research institutes in Europe and the United States, giving it one of the largest electrocardiogram databases in the world.
Idoven is currently experiencing exponential growth, with revenues increasing fivefold in less than four years, in a healthcare market estimated at over €10 billion a year worldwide. It has also entered into preventive partnerships with a number of professional soccer clubs, as well as with the AstraZeneca laboratory for the use of artificial intelligence to optimize and accelerate diagnosis and monitoring of heart failure patients over 65.
For its technological advances, Idoven has received numerous awards in Europe and the United States, including the European Innovation Council's prestigious Accelerator and Horizon 2020 awards, recognizing its ability to save lives.